Dr. Channing Der attended and presented a Distinguished Lecture at the Second Annual Meeting of the International Ovarian Cancer Consortium in conjunction with International Symposium on Tumor Microenvironment and Therapy Resistance August 16 – 18 . Dr. Der’s lecture, entitled ” Targeting RAS for Cancer Treatment: Mission Possible?” kicked off the second day of this fabulous conference. The Stephenson Cancer Center, University of Oklahoma Health Sciences Center hosted the Conference and Consortium which featured oral presentations, poster sessions, and keynote addresses on topics including Ovarian Cancer: Clinical Challenges, Ovarian Cancer Metabolomics, Tumor Microenvironment, Biomarker Discovery, Target and Therapy Resistance, and Cancer Chemoprevention.
Der Lab 